Open Access

What is the evidence for SGLT2 inhibitors in HF?

Topic: Chronic Heart Failure, Other
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Presentation

About the speaker

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
22 presentations
2 followers

3 more presentations in this session

Welcome and introduction.

Speaker: Professor J. Butler (Jackson, US)

Thumbnail

SGLT2 inhibitors for HF treatments in 2022 - What do the guidelines tell us?

Speaker: Professor G. Rosano (London, GB)

Thumbnail

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Access the full session

SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?

Speakers: Professor I. Pina, Professor J. Butler, Professor G. Rosano, Professor S. Anker
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk